3//SEC Filing
Atlas Venture Fund VIII, L.P. 3
Accession 0000899243-18-018430
CIK 0001693415other
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 6:34 PM ET
Size
12.4 KB
Accession
0000899243-18-018430
Insider Transaction Report
Form 3
Atlas Venture Fund VIII, L.P.
10% Owner
Holdings
- 90,000
Common Stock
Series B Preferred Stock
→ Common Stock (1,050,891 underlying)Series A Preferred Stock
→ Common Stock (2,326,567 underlying)Series C Preferred Stock
→ Common Stock (454,550 underlying)
Footnotes (4)
- [F1]The Series A Preferred Stock is convertible into Common Stock on a 5.5555-for-one basis into the number of shares of Common Stock shown in Column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date.
- [F2]The Series B Preferred Stock is convertible into Common Stock on a 5.5555-for-one basis into the number of shares of Common Stock shown in Column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date.
- [F3]The Series C Preferred Stock is convertible into Common Stock on a 5.5555-for-one basis into the number of shares of Common Stock shown in Column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date.
- [F4]These shares are held directly by Atlas Venture Fund VIII, L.P. ("Atlas Venture Fund VIII"). The general partner of Atlas Venture Fund VIII is Atlas Venture Associate VIII, L.P. ("AVA VIII LP"). Atlas Venture Associates VIII, Inc. ("AVA VIII INC") is the general partner of AVA VIII LP. Each of AVA VIII LP and AVA VIII INC disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Fund VIII, except to the extent of its pecuniary interest therein, if any. This report shall not be deemed to be an admission that the reporting persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose.
Documents
Issuer
Translate Bio, Inc.
CIK 0001693415
Entity typeother
Related Parties
1- filerCIK 0001451626
Filing Metadata
- Form type
- 3
- Filed
- Jun 26, 8:00 PM ET
- Accepted
- Jun 27, 6:34 PM ET
- Size
- 12.4 KB